Application of Membrane Technologies for Biomolecules Separation and Purification by Affinity Binding to Specific Ligands by FELINIA
  
APPLICATION OF MEMBRANE TECHNOLOGIES 
FOR BIOMOLECULAR SEPARATION AND 















A THESIS SUBMITTED FOR  
 
THE DEGREE OF MASTER OF ENGINEERING 
DEPARTMENT OF CHEMICAL AND 
BIOMOLECULAR ENGINEERING 







First of all, I would like to sincerely acknowledge my supervisor, Prof. Neal Chung 
Tai-Shung from the department of Chemical and Biomolecular Engineering, National 
University of Singapore for his guidance, suggestions, advices, and encouragements 
throughout my master study. 
 
Special thanks are given to Professor T. Alan Hatton from the Massachusetts Institute 
of Technology and Professor Raj Rajagopalan from the National University of 
Singapore for their invaluable suggestions. 
 
I also want to thanks the Singapore-MIT Alliance and the National University of 
Singapore for providing the research funding. 
 
Finally, I want to express my appreciation to my mentor, Dr. Li Yi and all of my 







Table of Contents 
 
Acknowledgments...................................................................................................... i 
Summary .................................................................................................................... iv 
List of Tables ............................................................................................................. v 
List of Figures ............................................................................................................ vi 
List of Symbols .......................................................................................................... vii 
 
Chapter 1. Background Review and Objectives 
1.1 Introduction  ................................................................................................... 1 
1.2 Methodologies of enantiomers separation  .................................................... 2 
1.3 Introduction to membrane for enantiomers separation  ................................. 4 
1.3.1 Enantioselective membranes .......................................................................... 5 
1.3.2 Non-enantioselective membranes  ................................................................. 6 
1.4 Introduction to affinity UF system  ................................................................ 7 
1.4.1 Affinity UF system performance parameters  ................................................ 7 
1.4.1.1 Enantioselectivity  .......................................................................................... 7 
1.4.1.2 Permeability ................................................................................................... 9 
1.4.2 Development of affinity UF system  .............................................................. 9 
1.4.3 Selection of stereoselective ligand  ................................................................ 12 
1.5 Formation of hollow fiber membranes by phase inversion  .......................... 14 
1.6 Research objectives  ....................................................................................... 16 
 
Chapter 2. Experimental 
2.1 Materials  ....................................................................................................... 17 
iii 
 
2.2 Dope preparation  ........................................................................................... 18 
2.3 Hollow fiber spinning  ................................................................................... 19 
2.4 Morphology study by FESEM  ...................................................................... 20 
2.5 Contact angle measurements ......................................................................... 20 
2.6 Module fabrications  ...................................................................................... 20 
2.7 PWP and pore size distribution characterizations  ......................................... 21 
2.8 Tryptophan separation performance  ............................................................. 22 
2.9 HSA denaturation and renaturation study  ..................................................... 23 
2.10 HSA regeneration and reusability  ................................................................. 26 
2.11  CD measurements of HSA  ............................................................................ 26 
 
Chapter 3. Exploration of Regeneration and Reusability of HSA as a 
Stereoselective Ligand for Chiral Separation in Affinity UF 
3.1 Characterizations of hollow fiber membranes  .............................................. 28 
3.2 Tryptophan separation of hollow fiber membranes  ...................................... 31 
3.3 Tryptophan separation of native and renatured HSA  ................................... 33 
3.4 Tryptophan separation of native and recovered HSA  ................................... 37 
 
Chapter 4. Conclusion  ............................................................................................ 40 
Bibliography  ............................................................................................................ 41 









The reusability of human serum albumin (HSA) as a stereoselective ligand for D,L-
tryptophan separation in the affinity ultrafiltration (UF) system has been demonstrated 
by readjusting the medium pH from an acidic condition to a basic condition in this 
study. The native and recovered HSA molecules exhibit a similar D,L-tryptophan 
separation factor of 5-7 under the same experimental conditions.  
 
In addition, a high recovery percentage of HSA of above 80% has also been obtained 
by controlling both the membrane pore size and membrane hydrophilicity. The 
combination of these two features (i.e. HSA reusability and high recovery) is very 
helpful for the large-scale industrial application of the affinity UF system in chiral 
separation.  
 
On the other hand, it has been found that the HSA binding capability to L-tryptophan 
could be affected by the solution ionic strength. A higher solution ionic strength may 
result in a decrease in amounts of L-tryptophan bound to HSA due to the changes in 
solution environment and HSA structure.  
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Chapter 1. Background Review and Objectives 
 
1.1 Introduction 
Chirality is a phenomenon used to describe any objects existing in two forms that lack 
of plan, center, and axis of symmetry and thus, creating a non-superimposable mirror 
image to one another. Chirality can be easily observed in the daily life from human 
body until small molecules possessing asymmetric carbon. The chemistry terms for 
those compounds are stereoisomers or enantiomers or enantiomorphs or chiral 
molecules [1]. The term racemic mixture is referring to the enantiomer ratio of 50/50.   
 
In 1930, it was discovered that different enantiomers possess different biological 
activities depending on their affinities towards enzyme or other receptor [2]. The 
enantiomer that strongly binds to the active sites of the receptor is called eutomer, 
while the enantiomer with a weaker association to the receptor is called distomer. This 
finding has significant impacts in enantiomers used as reagents in pharmaceutical as 
the distomer may not only reduce the activity of the eutomer but may cause toxic side 
effects. For instance, the thalidomide was previously prescribed as a sedative and 
antiemietic drug while it was found out later on that its R-enantiomer can cause 
teratogenic effects [3].        
     
Reflecting from the thalidomide tragedy, the U.S. Food and Drug Administration 
(FDA) established a new policy in 1992 for the development of new stereoisomeric 
drugs. It required every pharmaceutical company to identify the stereoisomeric 
composition of a drug with a chiral center together with the toxicological and 
pharmacological properties of the individual enantiomers [4]. The drugs need to be 
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administered in a pure enantiomer form if the other enantiomer is proven to possess 
different toxicological and pharmacological properties or any side-effects. This policy 
has created new markets for redevelopment of pure enantiomeric drugs that have been 
previously approved in a racemic form. Increasing public awareness of the possible 
hazard of racemic drugs has boast up the worldwide sales of the stereochemically 
pure drugs from 27% (US $74.4 billion) in 1996 to around 39% (US $151.9 billion) in 
2002 [5].     
 
To the present, there are two ways to produce single enantiomer drugs: synthesis and 
separation methods. Even though through the synthesis method, a high purity drug 
can be achieved yet its commercial application is still limited by the low yield. On the 
other hand, a high yield can be achieved through the separation method yet its cost 
inefficiency remains the limiting factor [6]. Therefore, the development of cost and 
time efficient enantioseparation methods for commercial production of the 
stereochemically pure drugs is urgently needed. 
 
1.2 Methodologies of enantiomers separation 
Depends on its applications, enantiomers separation can be classified into two main 
categories: analytical and preparative methods. Analytical method refers to any 
enantioseparation techniques aiming to analyze the stereoisomeric composition of 
chiral compounds. In analytical scale, the short testing time and high selectivity and 
sensitivity are compulsory. In this regard, the chromatography and electrophoresis 
techniques are able to suffice such requirements and commonly selected for 




Meanwhile, the most important factors for the preparative method are the high 
loading capacity and selectivity in order to improve the productivity. In industrial 
scale, the chromatographic and crystallization techniques are the most popular 
methods while membrane is considered as an emerging approach in the field of 
enantioseparation [7]. Various methodologies for separation of enantiomers are 
schematized in Fig. 1.1 while the merits and drawbacks of the existing 
enantioseparation techniques are summarized in Table 1.1.  
 
 
                              Analytical                                 Analytical/Preparative 







Table 1.1 Comparison of existing enantioseparation techniques [19] 
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1.3 Introduction to membrane for enantiomers separation 
Membrane processes have gained much attention recently in the field of enantiomeric 
separation owing to their cost and energy efficiency, suitability for continuous 
operation, feasibility for up-scaling, and ease of modification to accommodate 
different process configurations [7, 19]. Generally, membrane-based 
enantioseparation can be classified into two types: enantioselective and non-





1.3.1 Enantioselective membranes 
In the enantioselective membrane-based separation process, the membrane possesses 
chiral recognition sites which can selectively bind one of the two enantiomers. 
Depends on the membrane configuration, enantioselective membrane can be further 
classified into solid and liquid membranes. Solid enantioselective membranes can be 
directly prepared from phase inversion of the chiral polymers which by default posses 
chiral recognition properties, such as polyamino acids, polysaccharides, or 
polypeptides [21-22].  Other alternatives to fabricate enantioselective membranes are 
mixing the stereoselective ligands into non-chiral polymer solution before membrane 
casting [23] or immobilized the chiral selectors on the surface or membranes pores by 
grafting or molecular imprinting techniques [24-25].  
 
Separation mechanism for the solid enantioselective membrane can be categorized 
into two: diffusion-selectivity and adsorption-selectivity. The binding strength 
between the chiral recognition sites and enantiomers determines the separation 
mechanism, for example a weaker association is normally classified as a diffusion-
selectivity as it assists to slow down mass transport one of the enantiomers. 
 
As for the liquid enantioselective membranes, enantioseparation is facilitated by 
mobile chiral selectors dissolved in the liquid membrane phase which can selectively 
transport one of the enantiomers [26-27]. Liquid enantioselective membranes are 
gaining much interest owing to its low resistance for mass transfer compared to its 
solid counterpart. However, improvements on membrane durability are required for 




1.3.2 Non-enantioselective membranes     
Different from the enantioselective membranes, the separation mechanism for non-
enantioselective membranes is normally based on the size difference. As the 
enantiomers are typically identical in size, this process must be combined with other 
chiral recognition techniques to accomplish enantioseparation, for example catalyzed 
kinetic resolution [28-29] or enantiomer binding with stereoselective ligands [30-36]. 
The kinetic resolution is often catalyzed by enzymes, such as lipase to hydrolyze the 
enantiomers followed by membrane filtration to filter out the inhibitory byproducts. 
The differences in the separation principle between enantioselective and non-
enantioselective membranes are illustrated in Fig 1.2. 
 
 





The hybrid enantioseparation method combining non-enantioselective membrane with 
enantiomer-ligand complex is often referred as affinity UF. The working principle of 
the affinity UF is that after one enantiomer is bound selectively onto a large 
stereoselective ligand added to the bulk solution, the enantiomer-ligand complex is 
retained by a membrane, while the unbound enantiomer is transported across the 
membrane and collected on the permeate side. It is obvious that in the affinity UF 
system, the enantioselectivity is governed by selection of the stereoselective ligand. It 
is important to mention that non-enantioselective membranes have received great 
attentions owing to its convenience to combine the merits of different separation 
techniques and its potencies for large-scale enantioseparation [19]. Therefore, the 
non-enantioselective membrane particularly the affinity UF system will be discussed 
in detail in the next section.   
 
1.4 Introduction to affinity UF system     
1.4.1 Affinity UF system performance parameters 
Similar to other membrane separation process, the performance of affinity UF system 
can be defined by two parameters, namely selectivity and permeability. Both high 
selectivity and permeability are required to maximize system productivity.  
 
1.4.1.1 Enantioselectivity  
Enantioselectivity is an important factor in any separation system as it determines the 
purity of the final product. As for the affinity UF and other non-enantioselective 
membrane systems, the enantioselectivity is mostly attributed to the differences in the 
association between the seteroselective ligand and the two enantiomers. Generally, the 
stereoselective ligand possesses a stronger binding with one enantiomer developing 
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enantioselectivity yet non-stereospecific interactions may also occur through 
hydrogen bonding, hydrophobic, Coulombic, and van der Waals types of interaction 
[30]. Both enantiomers compete to bind to the non-stereospecific sites thus supressing 
the overall enantioselectivity.  
 
Many terms are used in the publications to define the enantioselectivity. The 
examples of the commonly used terms in the publications are separation factor (α) 
and enantiomeric excess (ee). The separation factor is defined as the concentration 
ratio between two enantiomers in the permeate solution divided by that in the feed 













α =   (1.1) 
where Cp,D and Cp,L are the concentrations of D-enantiomer and L-enantiomer in the 
permeate side, respectively, while Cf,D and Cf,L are the concentrations of D-enantiomer 
and L-enantiomer in the feed side, respectively. The separation factor is the most 
commonly used term for selectivity calculation in the affinity UF system. Therefore, 
for ease of comparison purposes, the selectivity presented in this study was calculated 
in terms of the separation factor.     
 
The enantiomeric excess is defined as the ratio of concentration difference in the 
permeation between two enantiomers divided by the concentration summation of both 
enantiomers [31]. The following equation is used to calculate the enantiomeric excess. 
, ,
, ,
100p D p L







  (1.2) 
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1.4.1.2 Permeability  
Another important factor that regulates the process productivity is permeability (Pm). 
As commonly observed in other porous membrane system, permeability is strongly 
dependent on membrane properties, such as membrane thickness, porosity, tortuosity, 
and pore size. With the trans-membrane pressure being the main driving force, the 








  (1.3) 
where Jv is the permeate flux (m/s), µ is the feed viscosity (kg/m.s), and ΔP is the 
trans-membrane pressure (kPa). The permeability is also reported in terms of 






where V is the volume of the permeate collected (L), A is the membrane area (m2), 
and t is the sampling time (hour). 
 
1.4.2 Development of affinity UF system 
The affinity UF system was firstly proposed in 1993 by Higuchi and coworkers [32]. 
They utilized 0.6 mM bovine serum albumin (BSA) as a stereoselective ligand for 
separation of 0.049 mM D,L-tryptophan racemic mixtures. The solution pH was varied 
from 7.0 to 3.0 and the effects on the enantioselectivity were investigated. It was 
reported that at pH 7.0, the permeate solution was mainly consisted of D-tryptophan 
inferring the preferential binding of L-tryptophan to BSA.  The separation factor of D-
tryptophan over L-tryptophan as high as 7 was attained, which demonstrates the 
feasibility of an affinity UF system for chiral separation. Interestingly, when the 
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solution pH was changed to 3.0, L-tryptophan was existed in the permeate solution 
indicating detachment of the L-tryptophan from the BSA binding sites at low pH. 
However, some important parameters were not reported in the manuscript, such as 
permeability and yield. The enantioseparation mechanism of D,L-tryptophan racemic 
mixtures with incorporation of BSA as a stereoselective ligand is depicted in Fig. 1.3.  
  
 
Figure 1.3 Separation mechanism of D,L-tryptophan racemic mixtures with BSA as a 
stereoselective ligand. (A) D,L-tryptophan in BSA solution, (B) L-tryptophan bound to 
BSA, (C) L-tryptophan ejected from HSA [32]  
 
Randon’s group [33] further investigated the association between BSA and the D,L-
tryptophan racemic mixture. They designed experiments to determine the 
stereospecific and non-stereospecific complexation constants between L-tryptophan 
and BSA at different solution pH. The relations employed are as follows: 






BSA + L  BSA-L          K =     (1.5)
BSA L
BSA-D
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S + L  S-L                      K  =         (1.7)
S L
BSA = BSA + BSA-L + BSA-D            (1.8)
D = D + BSA-D                                       (1.9)




They reported that the stereospecific complexation constant reached a maximum point 
at the solution pH of 9.0 (KL = 110,000) whereas the non-stereospecific complexation 
constant reached a maximum point at pH of 10.0 (K = 3,500). The enantioseparation 
of D,L-tryptophan racemic mixtures was then performed with the BSA solution. The 
highest D-tryptophan purity and recovery of 91% and 89%, respectively was attained 
at the solution pH of 9.0. However, there was not any detail provided on the tested 
system to achieve the enantioseparation reported in the mansucript.   
 
Afterwards, Zydney’s group [34-36] developed the affinity UF system through 
optimization of the single-stage UF system operating conditions and employment of 
multistage designs. Diafiltration system in which the fresh buffer was topped up into 
the feed solution to balance the loss of the permeate solution was proposed to 
eliminate the problems associated with the concentrated BSA in the feed. The L-
tryptophan yield was reported as a function of diavolumes which was obtained by 
dividing the volume of the collected permeates with the initial feed volume. By 
employing 0.6 mM BSA and 0.3 mM D,L-tryptophan racemic mixture dissolved in 
buffer solution with pH of 8.5, the highest separation factor of D-tryptophan over L-
tryptophan of around 11.0 was achieved at the beginning of the experiment. The 
separation factor was dropped to around 6.0 when the diavolumes was equal to 3. The 
authors explained that the degradation in the separation factor was caused by dilution 
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of the D-tryptophan remaining in the feed. Moreover, they also have demonstrated that 
the separation factor can be further increased to around 20.0 by employing the two-
stage affinity UF system.  
 
1.4.3 Selection of stereoselective ligand 
Generally, the criteria for selection of the stereoselective ligand in the affinity UF 
system are as follows: (1) a high intrinsic selectivity, (2) a much larger size compared 
to the enantiomers and hence the enantiomer-ligand complex can be easily retained by 
the UF membrane, and (3) feasibility to be regenerated and reuse. In most of the 
reported studies, tryptophan was commonly employed as the model enantiomers with 
various stereoselective ligands incorporated to achieved enantioseparation. The 
examples of the commonly used stereoselective ligands are cyclodextrins [37], 
deoxyribonucleic acid (DNA) [38], L-glutamic acid derivatives [39], and albumins 
[40].  
 
Albumin is a globular protein consisting of 585 amino acid residues and serves as a 
major transport protein in the circulatory system [41-42]. Up to the present, the most 
widely used albumin in the affinity UF system is albumin obtained from bovine 
(BSA). However, the difference in D,L-tryptophan association constants of BSA and 
HSA has been reported [43]. The L-tryptophan and D-tryptophan association constants 
for BSA are 1.5×10-4 M-1 and 0.23 ×10-4 M-1, respectively, while the L-tryptophan and 
D-tryptophan association constants for HSA are 1.1× 10-4 M-1 and 0.13 ×10-4 M-1, 
respectively. Thus, the intrinsic selectivity can be approximated from the ratio of 
association constants between the stereoselective ligand and two enantiomers. In this 
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regard, HSA possesses a higher intrinsic selectivity of L-tryptophan over D-tryptophan 
compared to BSA.    
 
HSA has been known to have two principal binding sites; namely, the warfarin-
azapropazone site (site I) and the indol-benzodiazepine site (site II) [44-45]. The 
characterization of these two binding sites by the displacement of fluorescent probe 
molecules from HSA by drugs has been done and it was suggested that electrostatic 
and dipolar forces contribute to the HSA specificity and binding affinity [45]. Later 
on, the binding chemistry of the site II of HSA in which the L-tryptophan is 
selectively bound was investigated through a series of studies by Peyrin et al. [46-49]. 
The binding mode was described in which the nonpolar residues inside the binding 
cavity of HSA were occupied by the hydrophobic groups of the bound molecule, 
while the cationic and polar residues of the cavity rim interacted with the carboxylate 
and sulfonalimido groups of the bound molecule. Therefore, the HSA selectivity 
towards L-tryptophan is determined by the arrangement of the hydrophobic 
functionalities together with the carboxylate and sulfonalimido groups of the L-
tryptophan molecule. Unless, a molecule possesses those groups in an arrangement 
fitted the binding cavity of HSA, it will not be attached to the stereospecific binding 
site of HSA. Moreover, the HSA selectivity towards L-tryptophan is also dependent on 
the HSA conformation as the dimension and structure of the binding cavity may 
change as the HSA conformation is disrupted leading to a loss of the HSA binding 
ability.       
 
It was previously reported that the conformational change of serum albumin occurring 
at pH = 3.0 effectively cause dissociation of bound L-tryptophan molecules [32]. 
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Further characterizations of HSA unfolding in the acid denatured state showed that a 
significant amount of the secondary structure was maintained, while a significant 
amount of the tertiary structure was lost [50]. This structural change may provide an 
opportunity for HSA regeneration after D,L-tryptophan separation. Nevertheless, the 
reusability of HSA depends on the reversibility of the HSA structure after acid 
denaturation.   
 
1.5 Formation of hollow fiber membranes by phase inversion 
Compared to the flat sheet membrane configuration, the hollow fiber configuration 
offers several advantages, namely a high membrane area per unit volume of 
membrane module, self-support ability, flexibility and ease of handling during module 
preparation and operation [51]. Therefore, the hollow fiber membrane configuration is 
preferable for membrane-based separations. Generally, the hollow fiber membrane 
prepared from the polymeric material is fabricated through the phase inversion 
process. The phase inversion of hollow fiber membrane is more complex than the flat 
sheet as it involves more parameters to alter the morphology of the final membrane 





Figure 1.4 Schematic of hollow fiber spinning [53] 
 
After being extruded from the spinneret, the internal surface of the nascent fiber is in 
direct contact with the bore fluid and thus, the internal coagulation starts to occur. The 
partial coagulation of the membrane outer surface starts at the air gap region as a 
result of the air relative humidity. The external coagulation is completed once the 
nascent fiber reaches the external coagulation bath. The inner and outer morphologies 
of membrane surface are governed by the chemistry of the bore fluid and the external 
coagulant, respectively. Water is often selected as the external coagulant to lower 
down the production cost and being an environmentally benign.  
 
Macrovoids have been considered as an undesirable structure irregularity due to its 
weaker mechanical strength which may cause membrane failure at high hydraulic 
pressure. Several methods were proposed to mitigate the macrovoids formation during 
phase inversion: (1) increasing the polymer dope viscosity [54], (2) increasing the 
extrusion rate of polymer dope and thus, increasing shear rate [55], (3) inducing a 
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delayed demixing [56], (4) adding surfactants [57], (5) adding viscosity-enhancer 
additives [58], and (6) reducing the air gap distance [59].      
  
1.6 Research objectives     
Despite of all the advantages possessed by the affinity UF system, its commercial 
application for enantioseparation is limited by the recovery and reusability of the 
stereoselective ligands. In this respect, the albumin particularly from human serum 
(HSA) has shown potencies due to the impermanent nature of the association with the 
enantiomer. Though during earlier investigation on the enantioseparation of 
tryptophan with BSA as a stereoselective ligand, it was revealed that the BSA 
undergoes conformational change at pH = 3.0 releasing the bound L-tryptophan 
molecules [32]. Nevertheless, further investigations are still needed to verify the 
conformational and binding reversibility of albumin after being denatured by acid. 
Therefore, the objective of this research is to investigate the regeneration and 
reusability of stereoselective ligands by utilizing both renatured and recovered HSA 
in the separation experiment of D,L-tryptophan racemic mixture. Moreover, this 
research is also aim to develop hollow fiber membrane with low-fouling property and 
appropriate pore size for complete retention of the enantiomer-ligand complex and 
thus, ensuring high recovery of the steroselective ligand for subsequent separations.      
17 
 
Chapter 2. Experimental 
 
2.1 Materials 
A commercial polyethersulfone (PES) was chosen as the polymeric material to 
fabricate the hollow fiber membranes. PES is preferred in this study because of its 
good thermal and chemical resistances, wide pH tolerance, ease of fabrication, and 
relatively low price [60]. A commercial Radel® A PES was obtained from Solvay 
Advanced Polymers L.L.C and N-Methyl-2-pyrrolidone (NMP) as a solvent was 
supplied by Merck.  
 
 
Figure 2.1 Chemical structure of PES polymer 
   
The application of PES membranes in biomolecules separation is limited by its 
hydrophobic property and thus, a rapid progressivity of membrane fouling is normally 
observed. Several surface modification methods were proposed to alter the membrane 
hydrophilicity, such as plasma treatment [61], grafting with hydrophilic monomers 
[62], sulfonation reaction [63], and direct blending with hydrophilic additives [64]. In 
this research, polyvinylpyrrolidone (PVP) with an average molecular weight of 360 
kDa purchased from Merck was selected as an additive. PVP is a water soluble 
material that is normally applied in the biomedical applications. In membrane 
fabrication, blending of PVP with hydrophobic polymers to increase the 
hydrophilicity of the resultant membrane has been reported [65-66]. In addition, PVP 
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is also functioned as a pore-former due to the feasibility of the unblended PVP to be 
removed from the membrane matrix. 
 
 
Figure 2.2 Chemical structure of PVP 
 
Sodium hypochlorite (NaOCl) from Acros and glycerol from Merck were used as the 
post-treatment agents for the hollow fiber membranes generated in this work. 
Polyethyleneglycol (PEG) from Merck with molecular weights of 1,000, 4,000, 6,000 
and 10,000 Da was used as a neutral solute for characterizations of pore size and pore 
size distribution of hollow fiber membranes. Disodium hydrogen phosphate 
(Na2HPO4), sodium dihydrogen phosphate (NaH2PO4), sodium hydroxide (NaOH) 
and phosphoric acid (H3PO4) were purchased from Merck for the preparation of 
buffer solutions. The racemic mixture of D,L-tryptophan (99%) was purchased from 
Alfa Aesar. Human serum albumin from Sigma-Aldrich (96-99%) was used as a 
stereoselective ligand. α-Cyclodextrine (α-CD) as a background electrolyte was 
purchased from CycloLab. All of these chemicals were of reagent grade and used as 
received.  
 
2.2 Dope preparation 
Both PES granules and PVP powders were dried at 120 ºC overnight under vacuum. 
The dried PES and PVP were then dissolved into a chilled NMP solvent under a 
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vigorous stirring until the homogeneous and viscous polymer dope was attained. 
Afterwards, the polymer dope was degassed overnight before spinning. 
 
2.3 Hollow fiber spinning 
The hollow fiber membranes were spun through the spinning line depicted 
schematically in Fig. 2.3. 
   
 
Figure 2.3 Schematic diagram of hollow fiber spinning line 
 
The bore fluid and polymer dope were pumped at different flow rates depending on 
the experimental conditions from the syringe pumps through the inner and outer 
channels of the spinneret, respectively. After being discharge from the spinneret, both 
solutions passed through the air gap region and entered the coagulant bath. The 
nascent fibers were collected at the take-up drum rotating at a predetermined rate. 
Subsequently, the as-spun hollow fibers were immersed in a water bath for several 
days to let the solvent exchange process occur.  The clean fibers were then immersed 
in an 8000 ppm sodium hypochlorite aqueous solution under stirring for 24 h in order 
20 
 
to remove the immiscible PVP from the membranes matrix. Afterwards, two different 
post-treatment procedures were performed: (1) soaking the membrane into a glycerol 
aqueous solution for the permeation and separation experiments and (2) freeze-drying 
the membrane for characterizations. 
 
2.4 Morphology study by FESEM 
The morphology of hollow fiber membranes was observed by the field emission 
scanning electron microscopy (FESEM) on a JEOL JSM-6700F. The samples were 
prepared by immersing the fiber in liquid nitrogen, fracturing and then coating with 
platinum using a JEOL JFC-1300 coater. 
 
2.5 Contact angle measurements 
The membrane contact angle was measured by a KSV Sigma 701 Tensiometer from 
KSV Instruments Limited. The sample was brought into contact with deionized (DI) 
water and the force was recorded simultaneously. The contact angle can then be 
calculated by the software upon inputting the sample geometry and the water surface 
tension. For each condition, the average contact angle value obtained from three 
samples was reported.   
 
2.6 Module fabrications 
The membrane modules were prepared by bundling 10 fibers for each module with a 
Teflon tape at both ends. The fiber bundle was inserted into a tubing (15 cm length) 
connected with two fittings. Afterward, the gap between the fiber bundle and the 
fitting was filled with the cotton before sealing with the epoxy. The similar procedure 
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was carried out for the other side of the module after the epoxy was completely 
hardened. 
 
2.7 PWP and pore size distribution characterizations 
Each module was rinsed with DI water to remove the glycerol before every 
characterization and separation experiments. The pure water permeability (PWP) and 
pore size distribution characterizations were carried out at 15 °C and 2 bar pressure. 
The experimental setup applied for both measurements are illustrated in Fig. 2.4.   
 
 
A = Feed tank, B = Cooling coil, C = Filter, D = High pressure pump, E = Pulsation 
damper, F = Bypass valve, G = Pressure gauge, H = Membrane module, I = Sampling 
valve, J = Rotameter 
 
Figure 2.4 Schematic diagram of self-designed UF setup for PWP and pore size 
distribution characterizations [67]  
 
For the characterization of pore size distribution, PEG solutions with different 
molecular weights (MW) were prepared for the solute rejection (RT) test. The Stokes 
radius (rs) of solutes with different MW was calculated using the following equation: 
log 1.32 0.395logsr MW= − +  (2.1)     
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The solute rejection (RT) can be expressed by a log-normal probability function of 
solute size [68] as shown in the following equation: 



















=  (2.3) 
where cp and cf are the permeate and feed concentrations, respectively, µs is the 
geometric mean solute radius at RT = 50%, rs is the solute radius, σg is the ratio 
between rs at RT = 84.13% to that at RT = 50%. By assuming the mean pore radius (µp) 
and the standard deviation (σp) are equal to µs and σg, respectively, the membrane pore 
size distribution can be expressed in the probability density function derived from Eq. 
(2) [69]: 





ln 2 2 ln
T p p p










where rp is the membrane pore radius.  
 
2.8 Tryptophan separation performance  
The first step was to prepare the racemic solution with a concentration of 0.1 mM by 
dissolving D,L-tryptophan powders in a 10 mM phosphate buffer adjusted to pH 9.0. 
HSA was then added to the racemic solution to achieve a molar ratio of 2:1 of HSA to 
tryptophan. Upon addition of HSA, there was a shift in solution pH and hence, 
sodium hydroxide was added to adjust the pH back to 9.0. The resulting solution was 
stirred for 3 h to reach the binding equilibrium. Thirdly, the HSA-tryptophan mixture 
solution was fed into the self-designed UF setup at 15 °C and 0.5 bar for the 
separation experiments. An overall-recycle mode where both retentate and permeate 
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solutions were recycled back to the feed tank was carried out to keep the 
concentration of the feed solution constant. During the experimental running, the 
permeate samples were collected at regular intervals and were analyzed using a 
P/ACETM MDQ capillary electrophoresis (CE) system from Beckman Coulter. Unless 
otherwise stated, the data were acquired using a 50 cm long fused silica capillary with 
an inner diameter of 75 µm from Agilent Technologies. 
 
The instantaneous separation factor (α) and the instantaneous yields of D-tryptophan 
and L-tryptophan (YD and YL) were calculated using the following equations: 
α =  Cp,D Cf,D⁄
Cp,L Cf,L⁄                  (2.5) YD = Cp,DCf,D  X 100%        (2.6) YL = Cp,LCf,L  X 100%         (2.7) 
where Cp,D and Cp,L are the concentrations of D-enantiomer and L-enantiomer in the 
permeate side, respectively, while Cf,D and Cf,L are the concentrations of D-enantiomer 
and L-enantiomer in the feed side, respectively. Both Cf,D and Cf,L were acquired 
before the addition of HSA powders. 
 
2.9 HSA denaturation and renaturation study 
A series of experiments were designed to explore the evolution of separation factor of 
HSA as a function of denaturation-renaturation times and to determine the percentage 
of HSA recovered at the end of each cycle mode.  Each cycle mode is an independent 
and parallel experiment as illustrated in Fig. 2.5. It could be seen that different cycle 
modes mean the different times of acidification and basification process before the 
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Figure 2.5 Schematic of HSA denaturation and renaturation experiments 
  
In the HSA denaturation and renaturation study, the separation experiment consisted 
of two parts, namely permeation part and recovery part as shown in Fig. 2.6. A 
continuous diafiltration mode was conducted at 15 °C and 0.5 bar to recover the HSA 
from the feed solution. Herein, only the retentate solution was recycled back to the 
feed tank and the fresh buffer was topped up into the feed tank to balance the loss of 





Figure 2.6 Schematic of tryptophan separation experiments for HSA denaturation and 
renaturation study under diafiltration mode 
 
The permeation part was run for 4 h and the amounts of D-tryptophan and L-
tryptophan collected at the permeate container were analyzed using the CE system. 
The overall separation factor (αo) and the overall yield of L-tryptophan (YL,o) were 
calculated using the following equation: 
αo =  np,D nf,D⁄np,L nf,L⁄              (2.8) YL,o = np,Lnf,L  X 100%            (2.9) 
where np,D and np,L are the moles of D-enantiomer and L-enantiomer in the collected 
permeate solution, respectively, at the end of the permeation part, while nf,D and nf,L 
are the initial moles of D-enantiomer and L-enantiomer in the feed solution, 
respectively. Both nf,D and nf,L were acquired before the addition of HSA powders. 
 
As shown in Fig. 2.6, the solution retained in the feed tank in the permeation part was 
used as a feed in the recovery part after reducing its pH value to 3.0 via the addition 
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of phosphoric acid. The same UF system and operating parameters were used as the 
permeation part with a running time of 5 h.  
 
At the end of each cycle mode, the HSA content in the retained solutions was 
analyzed with the CE system using a 50 cm long neutral polyacrylamide coated 
capillary with an inner diameter of 50 µm from Beckman Coulter. The recovery 
percentage of HSA (% Rec,HSA) was calculated using the following equation: % Rec,HSA =  Cr,HSACf,HSA  x 100%             (2.10) 
where Cr,HSA and Cf,HSA are the concentrations of HSA at the retentate and feed sides, 
respectively.  
 
2.10 HSA regeneration and reusability 
Fig. 2.6 can also be used to explore the reusability of the recovered HSA as a 
stereoselective ligand in the real case which included two steps of separation 
experiments, and the test was accomplished within two consecutive days. The first 
step was exactly the same as the 1-cycle mode in the HSA denaturation-renaturation 
experiment, whereas, in the second step, the HSA recovered from the first step was 
reused as a stereoselective ligand to separate the second batch of fresh tryptophan 
racemic mixture.  
 
2.11 CD measurements of HSA 
To characterize the structure of HSA in solutions with various pH values, Circular 
Dichroism (CD) measurements were conducted on a spectropolarimeter Jasco J-810. 
For all samples, the temperature was maintained at 15 ºC and the average result of 
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three scans was reported. The native HSA sample was prepared by dissolving HSA 
powders in a 10 mM phosphate buffer with a pH value of 9.0 to achieve a 
concentration of 0.75 g/l and 5 g/l for the far-UV CD and near-UV CD, respectively. 
Upon addition of HSA, there was a shift in solution pH and hence, sodium hydroxide 
was added to adjust the pH back to 9.0. The acid-denatured HSA sample was then 
prepared by adding phosphoric acid into the native HSA solution to reduce the pH 
value to 3.0 and afterwards, the base-renatured HSA sample was attained by adding 
sodium hydroxide to readjust the pH value back to 9.0. The ionic strength of the HSA 
samples was regulated by a dialysis membrane prior to CD measurements. 
 
The 1 mm pathlength cell was used for far-UV CD, while the 5 mm pathlength cell 
was used for near-UV CD. The buffer interference was eliminated by subtracting the 
buffer spectrum from the obtained sample spectra. The mean residue ellipticity (MRE, 
deg.cm2/dmol) was calculated using the following equation [71]: MRE =   θobs 
10 x CHSA x n x l  (2.11) 
where 𝜃obs is the CD measurement (mdeg), n is the number of amino acid residues, l is 
the cell pathlength (cm) and CHSA is the HSA concentration (M). The MRE obtained 
at the wavelength of 222 nm was further used to calculate the α-helical content using 
the following equation [71]: % helix = �MRE222−2340
30300
�X 100% (2.12) 
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Chapter 3. Exploration of Regeneration and Reusability of HSA as a 
Stereoselective Ligand for Chiral Separation in Affinity UF 
 
3.1 Characterizations of hollow fiber membranes 
The detailed dope compositions and spinning parameters for fabrication of hollow 
fiber membranes are summarized in Table 3.1. 
 
Table 3.1 Spinning parameters for hollow fiber membranes 
ID  Fiber-4.5cm Fiber-10cm Fiber-15cm 
Dope composition  PES/PVP/NMP (20/10/70 wt%) 
Bore fluid composition  NMP/water (86/14 wt%) 
Dope flow rate (ml/min)  2 
Bore fluid flow rate (ml/min)  0.8 
Air gap (cm)  4.5 10 15 
Take up rate (cm/min)  1240 
External coagulant  Water 
Spinning temperature (°C) 25 
Coagulation bath temperature (°C) 25 
 
The addition of PVP into the polymer dope mainly serves three purposes in this 
research. The first is to enhance the dope viscosity and thus retard the formation of 
macrovoids, which has been proven by the cross-sectional FESEM images of hollow 
fibers (Fig. 3.1). The second is to increase the membrane hydrophilicity [65-66] and 
consequently reduce the non-specific adsorption of the HSA and tryptophan 
molecules within the membrane which is very helpful to improve the HSA recovery. 
The third is to function as a pore forming agent due to the feasibility of the unblended 





Figure 3.1 Comparison of FESEM images of PES hollow fiber membranes spun at 
various air gap distances  
 
The pure water permeability, mean pore radius, geometric standard deviation and 
molecular weight cut-off (MWCO) of hollow fiber membranes spun at different air 
gap distances are given in Table 3.2, while the cumulative pore size distribution and 
probability density function curves are illustrated in Fig. 3.2.  
 






 bar h)) 
Mean pore radius 
(nm) Standard deviation 
MWCO 
(kDa) 
Fiber-4.5cm 74.79 + 4.85 3.1 + 0.03 1.68 + 0.01 10.92 + 0.17 
Fiber-10cm 105.37 + 2.46 3.43 + 0.09 1.66 + 0.04 13.28 + 0.51 





Figure 3.2 Cumulative pore size distribution (A) and probability density function (B) 
curves for hollow fiber membranes  
 
It can be seen in Table 3.2 that the PWP value increases as an order of fiber-4.5cm < 
fiber-10cm < fiber-15cm. This change is probably due to the increment in the 
elongational stress induced by gravity as the air gap distance increases. After being 
extruded from the spinneret, the outer surface of the nascent fibers contacts with the 
air and the moisture-induced phase separation occurs. Afterwards, a high elongational 
stress may draw polymer chains of the fibers at the initial stage of phase separation 
and hence, induce the formation of pores that is confirmed by the increment in 
membrane MWCO (Table 3.2) and the shifting in the pore size distribution curves 
(Fig. 3.2) with increasing air gap distance. 
 
A high rejection of HSA is one of prerequisites to ensure a high separation factor of 
the tryptophan racemic mixture in the affinity UF system. CE analyses of permeate 
solutions through three types of PES membranes developed in this study indicate that 
all membranes can fully retain HSA as shown by the capillary electropherograms in 





Figure 3.3 Capillary electropherograms of permeate samples via hollow fiber 
membranes 
 
3.2 Tryptophan separation of hollow fiber membranes 
A comparison of tryptophan separation factor among these three types of membranes 
is illustrated in Fig. 3.4. It can be seen that despite the difference in pore size 
distribution, all of them exhibit a similar separation performance with time. This 
implies that as long as the complete HSA rejection is attained, the separation factor is 
determined dominantly by the intrinsic association constants of HSA with two 









Figure 3.4 Comparison of tryptophan separation factor of hollow fiber membranes  
 
This point seems contradictory with the previous work reported by our group that 
suggested a suitable membrane pore size contributed to an enhanced separation 
performance [40]. This may be due to the difference in operation modes in these two 
works. The dead-end mode was used in the previous work, whereas the cross-flow 
mode where the feed solution flowed tangent to the membranes surface was used in 
the current work. Together with the addition of hydrophilic PVP and smaller 
membrane pore size (i.e. MWCO 19 kDa in the current work vs. 30 kDa in the 
previous work), the probability to retain the HSA molecules within the membrane 
cross-section is significantly reduced in this work and therefore, it may not provide a 
second-stage binding opportunity for L-tryptophan as shown in the previous work. 
Based on the above results, fiber-15cm was therefore selected as a specimen to 





3.3 Tryptophan separation of native and renatured HSA 
Comparisons of tryptophan separation of native and renatured HSA as well as HSA 
recovery as a function of denaturation-renaturation times are summarized in Table 3.3. 
 
Table 3.3 Overall separation factor, overall L-tryptophan yield and percentage of 




Overall L-tryptophan yield 
(YL,o) 
Percentage of recovered 
HSA (% Rec,HSA) 
1-cycle  5.29 + 0.28 10.62 + 0.08 87.62 + 4.42 
2-cycle  4.58 + 0.27 11.33 + 0.22 90.12 + 4.19 
3-cycle  4.49 + 0.3 11.84 + 0.34 83.88 + 3.56 
4-cycle  3.3 + 0.2 21.5 + 0.42 97.18 + 4.52 
5-cyclea - - - 
a The data could not be attained due to the HSA precipitation induced by a high salt 
concentration after several times of denaturation-renaturation process.  
 
It can be seen in Table 3.3 that after three times of denaturation-renaturation process 
are carried out in the 4-cycle mode, the overall tryptophan separation factor is > 3.0. 
This implies that by simply readjusting the medium pH value, the capability of HSA 
to selectively bind L-tryptophan over D-tryptophan can be recovered. Nevertheless, the 
overall separation factor decreases with increasing times of denaturation-renaturation 
process. There are two reasons that might be responsible for the decline in overall 
separation factors. One is that the acidic condition may induce an irreversible 
structural change of HSA, and the other is that the salt concentration in the HSA-
tryptophan mixture solution is enhanced by the continuous addition of phosphoric 




The CD technique was chosen to examine the structure of the native, acid-denatured 
and base-renatured HSA samples. The far-UV CD and near-UV CD spectra of these 
samples are shown in Fig. 3.5 A and Fig. 3.5 B, respectively. Since the HSA spectra 
after two or more times of denaturation-renaturation process are similar to those after 
one time, only the HSA spectra after one time are plotted.   
 
 
Figure 3.5 Far-UV CD spectra (A) and near-UV CD spectra (B) for native, one time 
acid-denatured and one time base-renatured HSA 
 
It can be seen in Fig. 3.5 A that the far-UV CD spectra for all HSA samples are 
similar yet with different intensities, and show two minima at 208 nm and 222 nm 
which indicate an α-helical structure. The MRE values obtained at the wavelength of 
222 and 262 nm as well as the calculated α-helical contents of the native, acid-









Table 3.4 Summary of far-UV CD and near-UV CD data for native, acid-denatured 
and base-renatured HSA with different denaturation-renaturation times 
  
MRE at 222 nm 
(deg cm2/dmol) 
% helix 
MRE at 262 nm 
(deg cm2/dmol) 
Native HSA 21,095 + 655 61.9 + 2.16 144.07 + 4.26 
1 time base-renatured  20,729 + 388 60.69 + 1.28 130.48 + 4.48 
2 time base-renatured  19,823 + 614 57.7 + 2.03 126.25 + 7.84 
3 time base renatured  19,350 + 520 56.14 + 1.71 128.46 + 5.31 
4 time base-renatured  18,329 + 493 52.77 + 1.6 119.89 + 4.96 
Acid-denatured HSA 14,259 + 383 39.34 + 1.19 110.05 + 4.55 
 
As shown in Table 3.4, the α-helical content of the native HSA is around 61%, while 
the acid-denatured HSA exhibits a much lower value suggesting that under the acidic 
condition, the structural change of HSA happens. It has been reported that in the 
acidic condition, hydrophobic forces, disulfide bonds, salt bridges and metal ion-
protein interactions that favor protein folding may fail to overcome the intramolecular 
charge repulsion that favors protein unfolding [73]. Another point worthy of notice in 
Fig. 3.5 A is that after adding the base to the pH value of 9.0, the acid-denatured HSA 
is able to refold to gain almost all of the secondary structures. Nevertheless, the α-
helical content in Table 3.4 shows a declining trend with increasing denaturation-
renaturation times.  
 
The near-UV CD is a useful technique to get insight of the tertiary structure of 
proteins [74]. It can be seen in Fig. 3.5 B that the near-UV CD spectra of the native, 
acid-denatured and base-renatured HSA samples are similar yet with different 
intensities, and show two minima at 262 nm and 268 nm which are characteristic of 
disulfide bond [75]. Similarly, the acid-denatured HSA with a much lower ellipticity 
value in Table 3.4 is able to refold to gain most of the tertiary structures after the 
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medium pH is readjusted back to pH 9.0. However, the ellipticity value of the base-
renatured HSA is lower than its native counterpart and declines with increasing 
denaturation-renaturation times, which imply that more of the tertiary structures may 
lose after more times of acidification. Both of far-UV CD and near-UV CD spectra 
suggest that the structural change of HSA might occur after acidification and 
basification, and its extent becomes more prominent with increasing denaturation-
renaturation times.    
 
Other than the structural change, the decline in overall separation factors with 
increasing denaturation-renaturation times in Table 3.4 is perhaps also due to the 
accumulation of buffer salts that leads to an increase in the solution ionic strength. 
The ionic strength promotes the electrolyte shielding, thus reducing the electrostatic 
attraction between the HSA and L-tryptophan. The similar phenomenon has been 
reported in a high performance liquid chromatography (HPLC) system where HSA 
was immobilized onto the HPLC column [76]. Moreover, the HSA binding cavity 
becomes less accessible with increasing ionic strength. This is because a higher ionic 
strength raises the surface tension that leads to an increase in hydrophobic interaction 
of nonpolar groups inside the HSA binding cavity and subsequently, a decrease in 
radii of the binding cavity [41]. As a result, both effects of ionic strength may reduce 
the amount of L-tryptophan molecules bound to HSA, hence causing more L-
tryptophan molecules to appear at the permeate side of membranes as shown in Table 
3.4.  
 
In addition, Table 3.4 displays a high recovery percentage of HSA of above 80% 
regardless of denaturation-renaturation times, which is very helpful to provide a 
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sufficient source for the following experiment of HSA reusability. The high recovery 
of HSA may be a synergistic effect of two factors. One is the suitable pore size of 
hollow fiber membranes developed in this work that prevents HSA molecules from 
entering and passing through the membrane. HSA has an approximate dimension of 
80 x 80 x 30 Å [77], while the membrane average pore sizes are in the range of 30-40 
Å (Table 3.2). The other is the improved hydrophilicity of membranes after the 
addition of PVP. The contact angle of PES/PVP membranes spun in this work is 63.0o 
± 1.1o, while the contact angle of neat PES membranes spun with the very similar 
polymer concentration (i.e. 21 wt%) in our group is 71.2o ± 1.7o. The improvement in 
hydrophilicity can significantly suppress the hydrophobic adsorption of HSA on the 
membrane surface, thus reducing membrane fouling. 
 
3.4 Tryptophan separation of native and recovered HSA  
Through the acid-denaturation followed by the base-renaturation, the feasibility of the 
renatured HSA as a stereoselective ligand for D,L-tryptophan separation has been 
demonstrated. However, it is more attractive for industrial applications to explore the 
feasibility of the HSA recovered from the previous separation experiment to be 
utilized as a stereoselective ligand in the subsequent separation experiment. Therefore, 
L-tryptophan and D-tryptophan yields between the native and recovered HSA are 
compared as a function of time in Fig. 3.6. It can be seen from Fig. 3.6 A that the 
yield of L-tryptophan is similar between both cases. On the other hand, the D-
tryptophan yield of the recovered HSA is higher than the native HSA as shown in Fig. 
3.6 B which may be due to the saturation of the non-stereospecific binding sites of 
HSA by the D-tryptophan molecules during the previous separation experiment. 
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Consequently, the separation factor of the recovered HSA is slightly higher than the 
native HSA as shown in Fig. 3.7.  
 
 
Figure 3.6 Comparison of yields of L-tryptophan (A) and D-tryptophan (B) between 
native (●) and recovered (○) HSA  
 
  
Figure 3.7 Comparison of tryptophan separation factor between native (●) and 
recovered (○) HSA  
 
Nevertheless, on the other hand, this result seems contradictory with the previous 
result in which the separation factor decreases with increasing denaturation-
renaturation times in Table 3.3. This discrepancy may arise from the fact that the 
solution ionic strength is different between these two experiments. A lesser amount of 
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buffer salts was retained in the first separation step of the HSA reusability experiment 
since during the HSA recovery after separation of the first batch of D,L-tryptophan, the 
acidic buffer solution was diluted by the top up buffer and most of the formed buffer 
salts were also transferred into the membrane permeate side. The difference between 
the denaturation-renaturation and reusability experiments may indirectly give a hint 
that the increment in solution ionic strength may be more responsible than the 





Chapter 4. Conclusion 
  
The following conclusions can be drawn from this work: 
1. In the affinity UF system operated with a cross-flow mode, the membrane pore 
sizes evaluated here did not affect the tryptophan separation performance provided 
that the complete rejection of HSA as a stereoselective ligand is attained. 
 
2. The binding capability of the acid-denatured HSA to L-tryptophan is recovered 
through the basification process.  
 
3. The tryptophan separation performance of the renatured HSA as a stereoselective 
ligand diminishes with increasing denaturation-renaturation times. Besides the 
irreversible structural change of HSA molecules caused by the acidification 
process, the increment in solution ionic strength may be a more responsible factor. 
A higher solution ionic strength may lead to a decrease in electrostatic attraction 
between HSA and L-tryptophan via electrolyte shielding and meanwhile, reduce 
the accessibility of the HSA binding cavity to L-tryptophan because of the 
shrinkage of the binding cavity area. 
 
4. A high recovery of HSA is achieved through tuning the membrane pore size and 
incorporating the hydrophilic PVP additives, which provides a good base for the 
study of HSA reusability. The native and recovered HSA samples exhibit a similar 
separation performance in this work, which demonstrates the reusability of HSA 
in reality and is very inspiring for the large-scale application of the affinity UF 
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